Menu
  • microONE Home
  • microONE Press Corner
    • microONE News
    • Media Info-German
    • Media Info-English
  • CBmed Home

microONE

Microplastic Particles: A Hazard for Human Health?

QUICK LINKS

Consortium Partners

Contact Info

Images & Videos

News

SAVE THE DATE! – Join us for the First Vienna Summit on Microplastics and Health 2022.

The microONE team is proud to announce a first scientific meeting and discussion forum being held on September 28, 2022 at Hotel Regina in Vienna, Austria. During the meeting, 10 internationally renowned experts will give keynote talks and there will be plenty of time for direct discussions and interaction.

Silke Christiansen (Erlangen, Germany), Georg Gübitz (Vienna, Austria), Melissa Mather (Nottingham, UK), Sibylle Trawöger (Würzburg, Germany), Suzanne Turner (Cambridge, UK), Dick Vethaak (Amsterdam, Netherlands), and Christa Schleper, 2022 Wittgenstein Awardee from Vienna, Austria, have already been confirmed as keynote speakers so far.

Read more

microONE and Friends lecture series – 1

A Short introduction to x-ray fluorescence imaging by Dr Theresa Staufer

We are excited to announce the start of the microONE & Friends lecture series. The first lecturer is Dr. Theresa Staufer who has gladly accepted to give her lecture on a topic “A short introduction to X-Ray Fluorescence Imaging”. She is a distinguished scientist working at the Laboratory of Experimental Physics at the University of Hamburg and is also a project leader at DESY’s Laser Laboratory. Her primary research area is deeply rooted in medical imaging pilot research. Since 2017, she has remarkably contributed to the organization of the laser laboratory by developing new laser diagnostics.

 Read more

Wittgenstein Award 2022 granted to microONE collaborator, Christa Schleper.

Published On: 27-JUN-2022.

This year’s “Austro-nobel prize”, worth 1.5 million Euros, was awarded to microbiologist Prof. Christa Schleper, University of Vienna, for her outstanding work on microorganisms. The whole microONE team congratulates her and her team to this fantastic achievement.

Read more

https://www.cbmed.at/wittgenstein-award-2022-granted-to-microone-collaborator-christa-schleper/https://www.cbmed.at/wittgenstein-award-2022-granted-to-microone-collaborator-christa-schleper/
More News

Micro- and nanoplastic particles (MNP) have been found in recent years in all parts of the world and in various organisms. In the human body MNP have been detected e.g. in stool, placenta, kidney or lungs – not surprising considering that we consume on average up to 5 grams (!) of MNP per week. Until now, the health effects of this exposure to MNP are almost completely unexplored, especially regarding tumor development, growth and dissemination.

microONE was designed to fill this substantial knowledge gap within a multinational, multidisciplinary, cross-sectorial approach. It aims to provide scientific evidence on whether – and if so, how – different particles influence tumor development and spread by using colorectal cancer (CRC), one of the most frequent tumor entities and prone to contact with MNP in the gut, as an example.

Hence, major objectives of microONE are:

  • TO DETERMINE THE POSSIBLE EFFECTS OF MNP ON THE DEVELOPMENT/SEVERITY OF CRC AND THE SURROUNDING ENVIRONMENT (MICROBIOME);

  • To investigate the interaction of MNP with drug targets and targeted drugs;

  • TO ESTABLISH PREDICTIVE BIOMARKERS THAT ALLOW A DIRECT RISK ASSESSMENT; AND

  • TO DEVELOP RECOMMENDATIONS FOR A SAFE USE OF PLASTICS IN THE FUTURE;

Briefly, interactions between MNP and primary tumor cells obtained directly from CRC patients will be explored, and a suitable medium-to-high-throughput method for the detection and characterization of MNP will be established and optimized. Supported by supercomputing, the MNP interactions with molecular targets (e.g. proteins) and targeted drugs (against CRC) will be simulated. The effects of exposure to MNP on the microbiome and possible ‘re-balancing’ effects of probiotics to MNP-induced changes will be explored. The application of labeled MNP in vitro and in vivo (specific tumor models) will help to determine the mechanisms how MNP influence cell growth, primary tumor formation and spontaneous metastasis. For the latter experiments, suitable primary, secondary and weathered MNP will be prepared and physico-chemically characterized. With the newly established analytics, tissue sections of CRC patients will be screened for MNP load in addition to standard immunohistochemical staining. Integrating these data will allow for direct assessment of molecular events and biological risk caused by plastic particles. MNP must be seen as a public health concern and it is important to identify actionable steps, identified in the course of this project, to prevent disease.

Many of the project parts are scientifically and partly also technologically uncharted territory and therefore bear a certain uncertainty concerning a successful conduction. On the other hand, the scientific evidence generated within microONE will certainly have far-reaching consequences for society and its approach to plastics.

Images

PreviousNext
123
Click here for more Images / Videos

WOLFGANG WADSAK
General Manager microONE

wolfgang.wadsak@cbmed.at

LUKAS KENNER
Scientific Lead microONE

lukas.kenner@cbmed.at

Contact

microone@cbmed.at

Consortium Partners:

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OKOptionsPrivacy policy

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Accept settingsHide notification only
Font Resize
Contrast

Warning: count(): Parameter must be an array or an object that implements Countable in /www/htdocs/w012ca72/wp-content/plugins/wp-accessibility-helper/inc/wah-front-functions.php on line 945

Warning: Invalid argument supplied for foreach() in /www/htdocs/w012ca72/wp-content/plugins/wp-accessibility-helper/inc/wah-front-functions.php on line 951
Accessibility by WAH